Santosh Prabhu
Divisional Vice President of Product Development for Abbott's Structural Heart Business, Abbott
Santosh Prabhu, PhD
Divisional Vice President of Product Development for Abbott's Structural Heart Business, Abbott
Product: TRICLIP™ G4 SYSTEM
Company: Abbott
About the Product:
In the U.S. alone, there are approximately 1.6 million people living with tricuspid regurgitation, or a leaky tricuspid valve, a condition in which patients have long faced limited treatment options such as medical therapy or high-risk surgery. Recognizing the unmet need of patients affected by this condition, Abbott developed the TriClip™ transcatheter edge-to-edge repair system to fill this critical treatment gap. TriClip is a first-of-its-kind, minimally invasive clip-based device designed specifically for the tricuspid valve to treat patients with this debilitating condition and has gone on to change the lives of more than 10,000 patients worldwide.
Steve Lisi
CEO and Chairman of the Board, Beyond Air, Inc.
Steve Lisi
CEO and Chairman of the Board, Beyond Air, Inc.
Product: LungFit® PH
Company: Beyond Air, Inc.
About the Product:
Recognizing the need for a simpler, more sustainable approach to inhaled nitric oxide (iNO) therapy, Beyond Air developed LungFit® PH—a next-generation, tankless, delivery system that generates NO directly from ambient air. This groundbreaking innovation eliminates the storage, handling and management of compressed gas cylinders, reducing logistical burden, environmental waste, and safety risks. By removing tanks and chemicals, LungFit PH streamlines workflows, enhances ease of use, and delivers significant cost savings compared to traditional systems—allowing hospitals to focus resources where they matter most: providing consistent, high-quality care to their most vulnerable patients.
John Osiecki
Vice President, North America Medical Affairs, bioMérieux
John Osiecki
Vice President, North America Medical Affairs, bioMérieux
Product: BIOFIRE® SPOTFIRE® System and BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panelv
Company: bioMérieux
About the Product:
The BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel is revolutionizing point-of-care diagnostics. Powered by cutting-edge multiplex PCR technology, it delivers highly accurate results for up to 15 respiratory or sore throat pathogens in ~15 minutes. Designed for simplicity, speed, and precision, the SPOTFIRE System integrates seamlessly into outpatient workflows and empowers clinicians to make confident, timely decisions. Born from bioMérieux’s legacy of syndromic testing, this innovation brings lab-quality diagnostics to urgent cares, clinics, and physician offices. By enabling faster diagnoses and more targeted treatments, SPOTFIRE is reshaping respiratory care and advancing global health—one patient and one test at a time.
Ania Garlitski
Global Medical Director, AF Solutions & CRM/Dx, Boston Scientific
Ania Garlitski
Global Medical Director, AF Solutions & CRM/Dx, Boston Scientific
Product: FarapulseTM
Company: Boston Scientific
About the Product:
The FARAPULSE™ Pulsed Field Ablation (PFA) System is backed by more clinical data and publications than any other PFA system, including over 250 publications and the largest PFA safety registry to date — the MANIFEST 17K Multicenter Registry. This groundbreaking, non-thermal system has treated over 200,000 patients worldwide, offering a safe, predictable alternative to traditional ablation. Using electrical pulses, it targets cardiac tissue while minimizing risk to adjacent structures like the esophagus and phrenic nerve. The adaptable FARAWAVE™ PFA Catheter conforms to diverse anatomies, empowering physicians with control and reproducibility. FARAPULSE is transforming AFib treatment — one pulse at a time.
Joe Landolina
CEO and Co-Founder, Cresilon
Joe Landolina
CEO and Co-Founder, Cresilon
Product: TRAUMAGEL®
Company: Cresilon
About the Product:
TRAUMAGEL® is a revolutionary plant-based hemostatic gel that controls bleeding in seconds. The groundbreaking medical technology from Brooklyn-based Cresilon is designed to stop bleeding rapidly, provide immediate hemorrhage control, and save lives. TRAUMAGEL is the first-ever gel in a syringe for traumatic hemorrhage and the only flowable hemostatic device with FDA clearance for temporary external use to control moderate to severe bleeding. Since its nationwide launch in January 2025, TRAUMAGEL’s clinical use has continued growing with licensed medical professionals applying it to a wide variety of moderate to severe bleeds, including gunshot wounds, equipment injuries, head lacerations, and tourniquet conversions.
Graig Eagle
Chief Medical Officer, Guardant Health
Graig Eagle
Chief Medical Officer, Guardant Health
Product: Guardant360® CDx
Company: Guardant Health
About the Product:
Our Guardant360® CDx liquid biopsy test is an FDA-approved comprehensive genomic profiling test for all solid tumors, helping doctors quickly inform treatment selection with an industry-leading turnaround time results of less than 7 days.
Ishu Rao
Medical Director, Impulse Dynamics
Ishu Rao
Medical Director, Impulse Dynamics
Product: Optimizer® Smart Mini System
Company: Impulse Dynamics
About the Product:
The Optimizer® Smart Mini delivers CCM® therapy to the heart, intended to improve heart contraction by sending electrical pulses to heart cells during the absolute refractory period, allowing more oxygen-rich blood to be pumped throughout the body. The treatment is indicated for HF patients having an LVEF ranging from 25 to 45% to enhance their quality of life by achieving the 6-minute hall walk and reducing HF symptoms, such as shortness of breath, fatigue, swelling, chest pain, and more. Impulse Dynamics completed numerous clinical studies and several controlled trials. CCM therapy has been published in over 120 peer-reviewed journal articles.
Zhou Yu
Chief Scientific Officer, OUR United
Zhou Yu
Chief Scientific Officer, OUR United
Product: TaiChiPro
Company: OUR United
About the Product:
TaiChiPro is the world's first integrated X/γ ray radiotherapy treatment device. It combines a linear accelerator (LINAC) with multi-source, rotating γ-ray technology to provide real-time tumor tracking. Cancer care providers can easily adjust treatment doses by using TaiChiPro’s intelligent imaging and AI capabilities, significantly reducing treatment time while protecting healthy tissues. TaiChiPro also strengthens clinical research by providing a platform to examine the application of radiation therapy for neurological disorders and pain management, while opening new avenues for personalized cancer therapy, new radiation biology insights, and combined immunotherapy approaches.
Samuel Mazin
Co-founder and CTO, RefleXion Medical
Samuel Mazin
Co-founder and CTO, RefleXion Medical
Product: RefleXion® X1 with SCINTIX® biology-guided radiotherapy
Company: RefleXion Medical
About the Product:
SCINTIX® biology-guided radiotherapy is a novel therapy that uses a single radiotracer injection to transform cancer cells into real-time biological beacons to direct external-beam radiotherapy to single or multiple tumors. SCINTIX therapy is cleared for use in FDG-directed treatment of primary or metastatic lung and bone tumors. For the first time, SCINTIX expands the scope of radiotherapy to treat metastatic patients who often are not candidates for radiotherapy due to the extent of their disease. This brings the proven safety, efficacy, and cost-effectiveness of radiotherapy to metastatic patients who desperately need new treatment options while also treating early-stage cancer patients.
John Anastasiadis
Sr. Director, Human Factors+Design, Smith & Nephew, Inc.
John Anastasiadis
Sr. Director, Human Factors+Design, Smith & Nephew, Inc.
Product: CORI Surgical System
Company: Smith & Nephew, Inc.
About the Product:
The CORI surgical robotics platform by Smith+Nephew revolutionizes orthopedic surgery with its advanced, miniaturized handheld robotics for partial, total, and revision knee procedures, eliminating the need for a bulky robotic arm. Unique in its use of a robotic digital tensioner, CORI ensures precise soft tissue balancing. It is the only platform offering both image-free and image-based solutions for knee and hip surgeries. With AI-powered personalized knee planning and 3D hip simulation pre-planning, CORI optimizes surgical outcomes, potentially reducing hip dislocation risks and enhancing patient quality of life through tailored intra-operative adjustments.